Psychedelic Stocks,Shroom News Filament Health Granted Patent for Extraction and Standardization of Natural Psilocybin By Dennis Mutua April 14, 2022 Clinical stage natural psychedelic drug development company supporting treatment of mental health conditions Filament Health Corp. (NEO: FH) (OTCQB: FLHLF) has received a patent allowing it to extract and standardize natural psilo...
Psychedelic Stocks,Shroom News Cybin Applies for International PCT Patent for Inhalation Delivery of Multiple Psychedelics Molecules By Dennis Mutua April 11, 2022 Biopharmaceutical company focusing on advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) announced that the World Intellectual Property ...
Psychedelic Stocks,Shroom News Silo Pharma Inks Agreement with Frontage Laboratories for Pharmacokinetic Study By Dennis Mutua April 01, 2022 Development stage biopharmaceutical company focusing on merging traditional therapies with psychedelic research Silo Pharma Inc. (OTCMKTS: SILO) has signed an agreement deal with Frontage Laboratories for Pharmacokinetic Study. ...
Featured,Shroom News Georgia Legislators Pass Bill to Form Psychedelic Study Committee By Dennis Mutua March 30, 2022 Lawmakers from Georgia have passed a bill advocating for the creation of a psychedelic study committee which will be dedicated in investigating the therapeutic potential of psychedelics like psilocybin, MDMA, DMT among others. The...
Psychedelic Stocks,Shroom News NeonMind Submits Patent Application for Psilocybin Induced Weight Loss By Dennis Mutua March 24, 2022 Integrated psychedelic drug development and wellness company focusing on therapeutic uses of psychedelics to address mental illnesses NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) has submitted a new patent application for ...
Psychedelic Stocks,Shroom News Nova Mentis Closes a Non-Brokered Private Placement By Dennis Mutua March 16, 2022 Biotechnology company focusing on developing diagnostics and psilocybin based therapeutics and complementary diagnostics for neuroinflammatory disorders Nova Mentis Life Sciences Corp. (CSE: NOVA) (OTCQB: NMLSF) announced having c...
Psychedelic Stocks,Shroom News Alberts Labs Starts Trading on CSE Following $4.7M Private Placement By Dennis Mutua March 11, 2022 Clinical research and drug development company focusing on patient access to psychedelic assisted therapies Albert Labs International Corp. has officially started trading on the Canadian Securities Exchange (CSE). Shares of the co...
Psychedelic Stocks,Shroom News Numinus Wellness CEO Discusses Upcoming Psilocybin and MDMA Clinical Trials By Dennis Mutua March 08, 2022 Payton Nyquvest, the chief executive of Numinus Wellness Inc. (TSE: NUMI) (OTCMKTS: NUMIF) a mental health and wellness company merging the practices of administering psychedelic medicine with holistic integrated psychotherapy has...